z-logo
open-access-imgOpen Access
Analysis of the Role of Selective Neck Dissection in Clinically Node-Positive T3/T4 Oral Cancers
Author(s) -
Dungala Dileep Maharaj,
Rajkumar Kottayasamy Seenivasagam,
Kinjal Shankar Majumdar,
Abhinav Thaduri,
Achyuth Panuganti,
Pallvi Kaul,
Jarang Rajesh Kumar,
Nooruddin Mohammed
Publication year - 2022
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2022/2204745
Subject(s) - medicine , neck dissection , perineural invasion , lymph node , dissection (medical) , stage (stratigraphy) , oncology , multivariate analysis , nodal , radiology , cancer , paleontology , biology
. The concept of selective neck dissection (SND) in locally advanced oral cancers is emerging. Contemporary studies support the feasibility of SND in selected node-positive oral cancers with early primaries. Nevertheless, the suitability of SND in clinically node-positive (cN+) oral cancers with advanced primaries (T3/T4) is unknown. Aim. This study explores if patients with cN+ advanced primaries were suitable candidates for SND by spotting the involved lymph node distribution in various stations of the neck. Secondary objectives were to check if predictive clinicopathological factors for metastases to the neck in general also apply for lymph node metastases to levels IV and V. Methods. The present retrospective study analysed the distribution of pathologically involved lymph nodes in 134 patients and explored the interrelation of various predictive factors and cervical metastases overall and those specific to levels IV and V. Results. Level V was involved in 6.7% (6/83) of T4 and none of the T3 primaries. Depth of invasion (DOI), perineural invasion (PNI), and skin invasion were statistically significant predictors for nodal metastases in general on multivariate analysis. Conclusion. Our analysis supports the option of considering SND, sparing level V in patients with cN+ oral cancers in a subset with T3 primary and nodal stage N2 and below.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom